Point72 Asset Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.6M | Buy |
|
|||||
|
2025
Q1 | $14.7M | Sell |
|
|||||
|
2024
Q4 | $15.7M | Sell |
|
|||||
|
2024
Q3 | $48.8M | Buy |
|
|||||
|
2024
Q2 | $38.6M | Buy |
|
|||||
|
2024
Q1 | $30.2M | Sell |
|
|||||
|
2023
Q4 | $66.6M | Buy |
|
|||||
|
2023
Q3 | $37.2M | Buy |
|
|||||
|
2023
Q2 | $33.6M | Sell |
|
|||||
|
2023
Q1 | $72.2M | Buy |
|
|||||
|
2022
Q4 | $50.1M | Buy |
|
|||||
|
2022
Q3 | $27.6M | Buy |
|
|||||
|
2022
Q2 | $1.6M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $2.4M | Sell |
|
|||||
|
2020
Q4 | $6.31M | Sell |
|
|||||
|
2020
Q3 | $6.46M | Sell |
|
|||||
|
2020
Q2 | $21.3M | Sell |
|
|||||
|
2020
Q1 | $40.3M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $3.24M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $705K | Buy |
|